BioCentury
DATA GRAPHICS | Deals

Data Bytes: how Warp Speed’s deals stack up

July 30, 2020 2:51 AM UTC

Moderna’s total COVID-19 vaccine funding from Operation Warp Speed is now up to $955 million after the company expanded its contract with the Biomedical Advanced Research and Development Authority (BARDA) this week.

That gives Moderna Inc. (NASDAQ:MRNA) the most R&D and manufacturing funding from the U.S. government for a COVID-19 vaccine -- without agreeing to supply doses. ...